2021 VCI Editorial Calendar

Topics of Discussion:

Through expert interviews, discussions, and market analysis, DCAT Value Chain Insights provides need-to-know information to keep pace with a changing marketplace:

  • The Global Pharma Watchlist: Tracking the performance of the global pharmaceutical industry and leading market sectors.
  • The CDMO/CMO Report: Market analysis of the key developments and trends in pharmaceutical outsourcing.
  • Manufacturing and Supply Lines: The latest in sourcing and the biopharmaceutical/ pharmaceutical manufacturing value chain.
  • The Pharma Pulse: Senior executives share the leading issues on their radar and of import to the pharmaceutical industry.

Plus, Top Industry News: To help ensure DCAT members never miss the most important stories impacting the global biopharmaceutical/pharmaceutical manufacturing value chain, DCAT delivers each Friday, the week’s Top Industry News, a companion newsletter to DCAT Value Chain Insights that highlights the top news stories of the week.

Have questions? Contact DCAT’s Editorial Director, Patricia Van Arnum, This email address is being protected from spambots. You need JavaScript enabled to view it., +1.609.208.1888 Ext 7014

 DCAT Value Chain Insights 2021 Editorial Calendar: January–December 2021

Issue Date Topic
January 6 The Global Pharma Watchlist: Global Pharma Outlook

Analysts provide an outlook on pharmaceutical industry performance for 2021 and beyond.
January 13 The CDMO/CMO Report: The Year Ahead in Pharma Outsourcing

Pharma/biopharma outsourcing expert Jim Miller, Content Advisor/Consultant, DCAT, provides an outlook for bio/pharmaceutical outsourcing for 2021.
January 20 Manufacturing and Supply Lines: Fine Chemicals

The outlook for fine chemicals supply and demand.

January 27 The Pharma Pulse: What is on the Horizon for 2021?

Senior executives give their take on the issues most impactful to the industry for 2021.


Top Industry News: Jan 8, 15, 22 and 29

 

February 3

The Global Pharma Watchlist: Biologics

Analysis of the leading products and recent drug approvals for biologic-based drugs.

February 10 The CDMO/CMO Report: Parenteral Drugs

A roundup of expansion activity among CDMOs/CMOs for sterile manufacturing, aseptic fill-finish and lyophilization.

February 17 Manufacturing and Supply Lines: API Sourcing

Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates.

February 24

The Pharma Pulse: Re-shoring Drug Manufacturing

Executives weigh in on policy proposals for re-shoring manufacturing respectively to the US and EU.

 

Top Industry News: Feb. 5, 12, 19 and 26

 

March 3

The Global Pharma Watchlist: Blockbuster Muscle

Analysis and market projections for new drugs, slated for market entry in 2021, with blockbuster potential.

March 10

The CDMO/CMO Report: Packaging

A roundup of expansions and technology advances in pharma packaging.

March 17

Manufacturing and Supply Lines: Inside Big Pharma’s Manufacturing Networks

The latest manufacturing expansion activity among the pharmaceutical majors.

March 24

The Pharma Pulse: Artificial Intelligence and Supply Management

Examining how digital tools, such as AI, are and potentially can be applied in supply management of APIs and drug products.

March 31

Special Report: DCAT Benchmarking

The results of DCAT’s latest benchmarking study examining topical issues in the pharma customer–supplier relationship.


Top Industry News: Mar. 5, 12, 19, 26 and Apr. 2

 

April 7

The Global Pharma Watchlist: Generics

Near-term market outlook for generic drugs.

April 14

The CDMO/CMO Report: Biomanufacturing

A roundup of expansion activity among CDMOs/CMOs in biomanufacturing.

April 21 Manufacturing and Supply Lines: Small-molecule APIs

Supply and demand market overview for small-molecule active pharmaceutical ingredients (APIs).

April 28 The Pharma Pulse: Emerging Pharma

Senior executives of bio/pharmaceutical start-ups and Emerging Pharma companies offer their views for successful product development.


Top Industry News: Apr. 9, 16, 23 and 30

 

 

May 5 The Global Pharma Watchlist: Pharma in a Post-Brexit World

The impact of Brexit on the pharmaceutical industry.

May 12 The CDMO/CMO Report: Solid-Dosage Drugs

The latest expansions and technology advances, including bioavailability enhancement, from CDMOs/CMOs in solid-dosage development and manufacturing.

May 19 Manufacturing and Supply Lines: Continuous Manufacturing

The latest projects and technology advances in continuous anufacturing for APIs and drug products.

May 26 The Pharma Pulse: Small Molecules and Biologics

Senior pharma executives weigh in on the evolving product mix between small molecules and biologics: current and future trends.


Top Industry News: May 7, 14, 21 and 28

 

June 2 The Global Pharma Watchlist: Cell and Gene Therapies

Market outlook and manufacturing expansions for cell and gene therapies.

June 9 The CDMO/CMO Report: What’s Trending in Pharma Outsourcing

Pharma/biopharma outsourcing expert Jim Miller, Content Advisor/Consultant, DCAT, analyzes key trends and developments in the CDMO/CMO sector.

June 16 Manufacturing and Supply Lines: Clinical Trial Material Supply

Best practices to optimize clinical trial material supply.

June 23 The Pharma Pulse: The Deal Makers

The top mergers and acquisitions thus far in 2021: the deal-makers and market impact.

June 30 Special Report: New Drug Approvals in 2021

Analysis of the new molecular entity approvals thus far in 2021.


Top Industry News: June 4, 11, 18, 25 and July 2

 

July 7 The Global Pharma Watchlist: India

Market overview and trends impacting pharmaceutical sourcing from India.

July 14 + July 21 DCAT Week, July 12–July 15, 2021, No issues
July 28 The CDMO/CMO Report: Top 10 Moves Thus Far in 2021

A look at the top mergers and acquisitions and expansion news from CDMOs/CMOs thus far in 2021.


Top Industry News: July 9, 16, 23 and 30

 

August 4 The Global Pharma Watchlist: Biosimilars

Market analysis and outlook for biosimilars.

August 11  The CDMO/CMO Report: Formulation Development/Drug Product Manufacturing

Latest market and technological advances for solid-dosage and parenteral drugs.

August 18 Manufacturing and Supply Lines: China

Market overview and trends impacting pharmaceutical sourcing from China.

August 25  N/A: No issue


Top Industry News: August 6, 13, 20 and 27

 

September 1 Global Pharma Watchlist: Small-molecule APIs

The top-selling small-molecule drugs and rising contenders.

September 8 The CDMO/CMO Report: End-to-End Service Models

An inside-the-trenches view of the end-to-end service model: CDMOs/CMOs providing both drug-substance and drug-product development and manufacturing.

September 15 Manufacturing and Supply Lines: Biomanufacturing

The latest capacity update and the industry’s fundamentals in biomanufacturing supply and demand.

September 22  The Pharma Pulse: Precision Medicine and Manufacturing

Executives weigh in on manufacturing strategies for lower-volume drugs created by personalized medicines and more targeted therapies.

September 29 Special Report: Global Pharma Pulse

Leading developments from the US, EU, China, India, and Central and South America.


Top Industry News: September 3, 10, 17, 24 and Oct 1

 

October 6 The Global Pharma Watchlist: Top Pharma Deals in 2021

The leading mergers and acquisitions among pharmaceutical companies thus far in 2021.

October 13 The CDMO/CMO Report: High-Potency Manufacturing

A roundup of recent expansions by CDMOs/CMOs and trends in high-potency manufacturing.

October 20 Manufacturing and Supply Lines: API Sourcing

Industry roundtable on key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates.

October 27 The Pharma Pulse: Project Management

Senior executives share case studies in innovation in project management with CDMOs/CMOs.


Top Industry News: October 8, 15, 22 and 29

 

November 3 The Global Pharma Watchlist: The Key Pipeline Contenders

Late-stage drug candidates with strong market potential.

November 10 The CDMO/CMO Report: Injectable Drugs

Industry roundtable on key trends and technological developments for injectable drugs, including drug-device technology.

November 17 Manufacturing and Supply Lines: Biomanufacturing

The latest biomanufacturing expansions by the pharmaceutical majors.

November 24 N/A: No Issue


Top Industry News: November 5, 12, 19 and 26

 

December 1 The Global Pharma Watchlist: The Year in Review

A look at the top developments from 2021.

December 8 The CDMO/CMO Report: The Movers and Shakers of 2021

A look at the top expansions and mergers/acquisitions from CDMOs/CMOs in 2021.

December 15 Manufacturing and Supply Lines: Fine Chemicals

Market outlook and key trends in the chemical manufacturing value chain for intermediates and active pharmaceutical ingredients.


Top Industry News: December 3, 10 and 17